Boston Scientific announced the U.S. launch of the DIRECTSENSE™ Technology for cardiac ablation catheters market
Growing
catheter ablation procedures around the globe are primarily fueling growth of
the cardiac ablation catheters market. According to the U.S. Department of
Health & Human Services, it is estimated that 12.1 million people in the
United States will have AFib in 2030. In 2018, AFib was mentioned on 175,326
death certificates and was the underlying cause of death in 25,845 of those
deaths. Moreover, the rising aging population is again increasing prevalence of
atrial fibrillation, atrial flutter and supraventricular tachycardia, and a
decrease in heart muscle elasticity condition. This factor will also stimulate
the growth of the market. According to the study by American Heart Association
in 2017, catheter-based ablation procedures claim a 90% success rate with minimum
risk of complications allowing patients to resume normal activities within a
few days, thereby growing the demand for ablation catheters in surgical
procedures.
Rising
prevalence of cardiac arrhythmia fuels the cardiac ablation catheters
market
Catheter ablation procedures are
expected to become a prevalent method of treating cardiac arrhythmias owing to
the cost effective and safe treatment method. According to American Heart
Association, around 33.5 million people were suffering from atrial fibrillation
globally in 2013.
Comments
Post a Comment